Treatment failure of nosocomial pertussis infection in a very-low-birth-weight neonate

Journal of Clinical Microbiology

Volumn 44, Issue 10, 2006, Pages 3830-3832

  Bonacorsi, Stéphane ^a   Farnoux, Caroline ^b   Bidet, Philippe ^a   Caro, Valérie ^c   Aizenfisz, Sophie ^b   Benhayoun, Mounir ^b   Aujard, Yannick ^b   Guiso, Nicole ^c   Bingen, Edouard ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; COTRIMOXAZOLE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; ERYTHROMYCIN; JOSAMYCIN; ANTIINFECTIVE AGENT; DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; CASE REPORT; CLINICAL FEATURE; HOSPITAL INFECTION; HUMAN; INFANT; MALE; PERTUSSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT FAILURE; VERY LOW BIRTH WEIGHT; CROSS INFECTION; IMMUNOLOGY; NEWBORN;

BORDETELLA PERTUSSIS;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CROSS INFECTION; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; JOSAMYCIN; MALE; TREATMENT FAILURE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; WHOOPING COUGH;

EID: 34248656465     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01062-06     Document Type: Article

References (14)

1. Baron, S., E. Njamkepo, E. Grimprel, P. Begue, J. C. Desenclos, J. Drucker, and N. Guiso. 1998. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr. Infect. Dis. J. 17:412-418.
2. Bartkus, J. M., B. A. Juni, K. Ehresmann, C. A. Miller, G. N. Sanden, P. K. Cassiday, M. Saubolle, B. Lee, J. Long, A. R. Harrison, Jr., and J. M. Besser. 2003. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J. Clin. Microbiol. 41:1167-1172.
3. Bassinet, L., M. Matrat, E. Njamkepo, S. Aberrane, B. Housset, and N. Guiso. 2004. Nosocomial pertussis outbreak among adult patients and healthcare workers. Infect. Control Hosp. Epidemiol. 25:995-997.
4. Cherry, J. D., E. Grimprel, N. Guiso, U. Heininger, and J. Mertsola. 2005. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr. Infect. Dis. J. 24:S25-34.
5. Edelman, K., S. Nikkari, O. Ruuskanen, Q. He, M. Viljanen, and J. Mertsola. 1996. Detection of Bordetella pertussis by polymerase chain reaction and culture in the nasopharynx of erythromycin-treated infants with pertussis. Pediatr. Infect. Dis. J. 15:54-57.
6. Gilberg, S., E. Njamkepo, I. P. Du Chatelet, H. Partouche, P. Gueirard, C. Ghasarossian, M. Schlumberger, and N. Guiso. 2002. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J. Infect. Dis. 186:415-418.
7. Langley, J. M., S. A. Halperin, F. D. Boucher, and B. Smith. 2004. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics 114:e96-101.
8. Nouvellon, M., J. F. Gehanno, M. Pestel-Caron, C. Weber, J. F. Lemeland, and N. Guiso. 1999. Usefulness of pulsed-field gel electrophoresis in assessing nosocomial transmission of pertussis. Infect. Control Hosp. Epidemiol. 20:758-760.
9. Pichichero, M. E., W. J. Hoeger, and J. R. Casey. 2003. Azithromycin for the treatment of pertussis. Pediatr. Infect. Dis. J. 22:847-849.
10. Steinberg, J. M., and I. Srugo. 2002. Reoccurrence of culture-positive pertussis in an infant initially treated with azithromycin and steroids. Arch. Pediatr. Adolesc. Med. 156:1057-1058.
11. Templeton, K. E., S. A. Scheltinga, A. van der Zee, B. M. Diederen, A. M. van Kruijssen, H. Goossens, E. Kuijper, E. C. Claas, K. Kosters, U. Reischl, J. Schmetz, M. Riffelmann, C. H. Wirsing von Konig, N. Lehn, G. N. Sanden, and M. J. Loeffelholz. 2003. Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J. Clin. Microbiol. 41:4121-4126.
12. Torre, D., F. Maggiolo, and C. Sampietro. 1984. Comparative clinical study of josamycin and erythromycin in pertussis. Chemioterapia 3:255-257.
13. Weber, C., C. Boursaux-Eude, G. Coralie, V. Caro, and N. Guiso. 2001. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J. Clin. Microbiol. 39:4396-4403.
14. Wirsing von Konig, C. H., M. Campins-Marti, A. Finn, N. Guiso, J. Mertsola, and J. Liese. 2005. Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations. Pediatr. Infect. Dis. J. 24:S87-S92.